Bagher Seyedalipour | Biochemistry Award | Best Researcher Award

Posted on by ScienceFather

Assoc. Prof. Dr. Bagher Seyedalipour | Biochemistry Award | Best Researcher Award

Biochemistry, University of Mazandaran, Iran

 

Assoc. Prof. Dr. Bagher Seyedalipour is a distinguished biochemist at the University of Mazandaran, specializing in protein engineering and proteomics. With a Ph.D. from Tehran University, he teaches and conducts advanced research on protein structures and gene manipulation techniques, especially using recombinant DNA. His laboratory focuses on creating therapeutic proteins, like luciferase and superoxide dismutase, exploring their functions and effects through site-directed mutagenesis. Dr. Seyedalipour’s work advances understanding of pathogenic mutations, contributing significantly to molecular biology and therapeutic biochemistry. 🔬🧬

 

Publication Profile

Scopus

Orcid

Academic Background

Dr. Bagher Seyedalipour is an accomplished biochemist with a profound dedication to academic research and teaching. He has developed an extensive foundation in the field of biochemistry through his rigorous education and current academic pursuits at the University of Mazandaran.

Education and Qualifications

Dr. Seyedalipour’s academic journey began with a Bachelor of Science in Biology from Shahid Beheshti University, Tehran. He furthered his expertise with a Master’s degree in Biochemistry from Tarbiat Modares University, followed by a Ph.D. in Biochemistry from the Institute of Biochemistry and Biophysics at Tehran University. His extensive training equips him with in-depth knowledge across biochemical sciences, particularly in protein engineering and molecular biology.

Teaching and Research Interests

Dr. Seyedalipour teaches courses on Biochemistry, Structure, Metabolism, and Advanced Molecular Biology for undergraduate and graduate students. His laboratory is primarily focused on Enzymology, Protein Engineering, and Proteomics, aiming to characterize and manipulate genes using recombinant DNA technology. His research highlights include the expression and production of therapeutic proteins, such as luciferase, superoxide dismutase, and uricase, where he applies site-directed mutagenesis for mutation analysis and to explore mutation-pathogenicity relationships.

Conclusion

Dr. Bagher Seyedalipour is a strong candidate for the Research for Best Researcher Award. His work in biochemistry, particularly his focus on protein engineering and pathogenic mutation analysis, stands out in its potential impact on therapeutic advancements and our understanding of molecular biology.

Publication Top Notes  

  • 🧬 “Mutation/metal deficiency in the electrostatic loop enhanced aggregation process in apo/holo SOD1 variants: implications for ALS diseases,” Ashkaran, F., Seyedalipour, B., et al. – BMC Chemistry (2024)
  • 🧬 “Implications of ALS-Associated Mutations on Biochemical and Biophysical Features of hSOD1 and Aggregation Formation,” Mohammadi, S., Seyedalipour, B., et al. – Biochemical Genetics (2024), 1 citation
  • 🧬 “GSTP1-A313G genetic polymorphism and the risk of preeclampsia in pregnant women: A study in the northern population of Iran,” Jalalian, E.J., Seyedalipour, B., et al. – Pregnancy Hypertension (2024)s
  • 🧬 “1,4-Diol Hq (TBHQ) vs 1,4-dithiol (TBDT); simulation of safe antioxidant with a lower carcinogenic activity,” Mosavi, S.Z., Seyedalipour, B., et al. – Science Progress (2024)
  • 🧬 “Exploring the anti-amyloid potential of salvianolic acid A against the ALS-associated mutant SOD1,” Waheed, Z.A., Seyedalipour, B., et al. – Molecular Simulation (2024), 1 citation
  • 🧬 “Catharanthine, an anticancer vinca alkaloid: in silico and in vitro analysis of the autophagic system,” Gholami, F., Seyedalipour, B., et al. – Naunyn-Schmiedeberg’s Archives of Pharmacology (2024)
  • 🧬 “Polyphenolic flavonoid compounds as inhibitors of aggregation in FALS-associated D101G SOD1 mutant,” Qassim, H.M., Seyedalipour, B., et al. – Computational Biology and Chemistry (2023), 4 citations
  • 🧬 “Role of charged residues of the “electrostatic loop” of hSOD1 in aggregation under amyloidogenic conditions,” Mavadat, E., Seyedalipour, B., et al. – International Journal of Biological Macromolecules (2023), 6 citations
  • 🧬 “A double point mutation of SOD1 targeting net charge promotes aggregation,” Mavadat, E., Seyedalipour, B., et al. – Biochimica et Biophysica Acta (2023), 5 citations
  • 🧬 “Sensitive determination of urea in luciferin chemiluminescence system,” Nemati, A., Seyedalipour, B., et al. – Chemical Papers (2023), 1 citation

 

 

Asif shahzad | Medical Biochemistry | Best Researcher Award

Posted on by ScienceFather

Dr. Asif shahzad | Medical Biochemistry | Best Researcher Award

Dr. Asif shahzad, Kunming Medical University Yunnan China

Dr. Asif Shahzad is a Research Associate in Medical Biochemistry at Kunming Medical University, China, specializing in metabolic reprogramming of clear cell renal cell carcinoma (ccRCC). With 15+ international publications, his research also focuses on natural compounds in oncology and synbiotic feed supplements for poultry growth. He previously worked on HCV treatment and poultry nutrition at Government College University, Faisalabad, Pakistan. Dr. Shahzad actively collaborates with global researchers and is a member of several scientific organizations, contributing significantly to advancements in biochemistry and oncology. 🌱🧪🔬

Publication profile

Google Scholar

Academic and Professional Background

Dr. Asif Shahzad is a Research Associate in Medical Biochemistry and Molecular Biology at Kunming Medical University, Yunnan, China, under the mentorship of Prof. Dr. Zhang Qiao. His work focuses on metabolic reprogramming in clear cell renal cell carcinoma (ccRCC), with 15+ publications in high-impact journals. Previously, he contributed to research at Government College University, Faisalabad, Pakistan, exploring serine protease inhibitors for HCV treatment and developing synbiotic feed supplements for poultry under the guidance of Prof. Dr. Shagufta Kamal. He is an active member of various biochemistry and oncology societies, demonstrating a strong commitment to advancing scientific knowledge.

Research and Innovations

Dr. Shahzad has participated in numerous research projects. He was a Research Associate on an HEC-funded project that explored serine protease inhibitors as a novel therapeutic approach for HCV. He also contributed to a PHEC project developing a synbiotic feed supplement for poultry. Currently, he leads a project on bioactive peptides from plant species and their potential therapeutic effects against HCV. His ongoing research includes a study on Moringa oleifera’s anti-ccRCC properties. His work exemplifies a versatile research portfolio that bridges human health and animal nutrition innovations.

Areas of Research

Dr. Shahzad’s research interests span several fields, including metabolic reprogramming in cancer, natural compounds in oncology, synbiotics in animal nutrition, amino acid analysis, and biocatalysis. His multidisciplinary research combines both human and animal health sciences, showcasing his ability to contribute to diverse scientific fields.

Publication Top Notes

  • An overview of free Radicals & antioxidants and its Deleterious actions 🧪📚 A Shahzad, S Hussain, N Anwar, A Karim, U Aeman, MJ Iqbal | Cited by 4 | 2021
  • Modulation of Metabolic Pathways and Protection against Cadmium-Induced Disruptions with Taxifolin-Enriched Extract 🧬🛡️ MF Khalid, MSH Akash, K Rehman, A Shahzad, A Nadeem | Cited by 1 | 2024
  • Biochemical investigation of association of arsenic exposed polymorphic variants and disease susceptibility 🔬🧬 SM Shoaib, S Afzal, MSH Akash, K Rehman, A Hussain, A Nadeem, A Shahzad | 2025
  • Innovative lipid nanoparticles: A cutting-edge approach for potential renal cell carcinoma therapeutics 💊🧫 A Shahzad, Z Teng, M Yameen, W Liu, K Cui, X Liu, Y Sun, Q Duan | 2024
  • Therapeutic Intervention of Serine Protease Inhibitors against Hepatitis C Virus 🦠💊 S Kamal, A Shahzad, K Rehman, K Tariq, MSH Akash, M Imran, MA Assiri | 2024
  • Biochemical Investigation of Therapeutic Efficacy of Berberine-Enriched Extract in Streptozotocin-Induced Metabolic Impairment 🧪🩺 MSH Akash, S Yaqoob, K Rehman, A Hussain, Z Chauhdary, A Nadeem, A Shahzad | 2024
  • Biosynthesis and Multifaceted Characterization of Breynia nivosa-Derived Silver Nanoparticles: An Eco-Friendly Approach for Biomedical Applications 🌿⚗️ K Irshad, MSH Akash, K Rehman, A Nadeem, A Shahzad | 2024
  • The Impact of Gut Bacterial Metabolites on Brain Disorder 🧠🦠 A Shahzad, S Hussain, R Mehmood, MN Jaan | 2022
  • A Medical Approach for Rhinoplasty 👃🩺 A Shahzad, S Hussain, A Karim, HMA Farooq, S Azam, U Hameed | 2022
  • Impact of Obesity in Male and Female Infertility ⚖️🧬 DEM Razia, A Shahzad, S Hussain, NB Qureshi, N Anwaar, A Aftab | 2021


Conclusion

Dr. Asif Shahzad’s innovative research in cancer metabolism and animal nutrition, combined with his editorial, collaborative, and professional contributions, makes him a strong candidate for the Best Researcher Award. His research’s impact on both human and animal health sectors aligns with the award’s recognition of excellence and innovation in scientific inquiry.